BioSpace News Archive

Darmiyan, Inc. is pleased to announce the initial closing of a $6M Series Seed investment round led by the pharmaceutical giant Eisai, creating a major business collaboration opportunity between the two companies, one focused on advanced brain diagnostics, and the other focused on Alzheimer’s therapeutics.

FOXO BioScience today announced the completion of an agreement to bring DNA methylation-based testing services of laboratory mice to the scientific research community. FOXO collaborated with Van Andel

NeuroMetrix, Inc. (Nasdaq: NURO) today announced that, due to the public health impact of the COVID-19 pandemic and in accordance with orders issued by the Governor of the Commonwealth of Massachusetts, the Company’s 2020 Annual Meeting of Shareholders (the “Annual Meeting”) will be held in a virtual meeting format only. The previously announced date and time of the Annual Meeting (April 28, 2020 at 9:00 a.m., Eastern Time) have not changed. Th

Magellan Health, Inc. (NASDAQ: MGLN), one of the nation’s leaders in behavioral health, today announced that it has opened a free national 24-hour crisis line for all first responders and healthcare workers who are serving on the front lines battling the coronavirus pandemic.

Today, the U.S. Food and Drug Administration approved Koselugo (selumetinib) for the treatment of pediatric patients, 2 years of age and older, with neurofibromatosis type 1 (NF1), a genetic disorder of the nervous system causing tumors to grow on nerves.

Evofem Biosciences, Inc. (NASDAQ: EVFM), a clinical-stage biopharmaceutical company, today announced that on April 9, 2020, the Compensation Committee of the Company’s Board of Directors approved the grant to 20 new employees of (i) non-qualified stock option awards to purchase an aggregate of 357,000 shares of common stock, and (ii) 20,000 restricted shares of common stock awards in aggregate.

Quanterix Corporation (NASDAQ: QTRX), a company revolutionizing digital biomarkers, joined forces with PPH in the fight against COVID-19

CA Veterinary Medical Board announces telemedicine may only be used with existing patients and for preexisting conditions, according to PetHospice

Neogen Corporation announced that James Herbert has resigned as its chairman, and he has been succeeded by Jim Borel.

The U.S. Food and Drug Administration announced the following actions taken in its ongoing response effort to the COVID-19 pandemic